Pacira BioSciences, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Pacira BioSciences, Inc.PCRX3d

   Pacira BioSciences reports insider trading

   • 10/08/2026: 6,000 shares bought
   • 10/08/2026: 6,000 shares sold
   • Insider is Senior Vice President, Finance

   Lauren Riker, reporting

2. NOTABLESCHEDULE 13D/APacira BioSciences, Inc.PCRX5d

   Pacira BioSciences, Inc. 13D/A filed by Doma Perpetual Capital Management LLC

   • Filed on 2026-10-13
   • Amendment No. 4
   • Reporting persons include Doma Perpetual Capital Management LLC

   Doma Perpetual Capital Management LLC, filed by

3. ROUTINESC TO-CPacira BioSciences, Inc.PCRXOct 8

   Viatris to Acquire Pacira for $36.50 per Share

   • $36.50 per share cash offer
   • Aggregate equity value of $1.65 billion
   • Tender offer open for 10 business days

   Viatris Inc, filed by

4. MAJOR8-KPacira BioSciences, Inc.PCRXOct 8

   Pacira BioSciences agrees to $36.50 per share acquisition

   • Entered into a merger agreement with Viatris Inc. on 2026-10-08
   • Tender offer to acquire all outstanding shares at $36.50 per share
   • Merger to be completed after tender offer, with no shareholder vote required
5. ROUTINE144Pacira BioSciences, Inc.PCRXOct 8

   Pacira BioSciences files Form 144

   • Filer: Riker Lauren
   • 6000 shares to be sold
   • Date of sale: 10/08/2026

   Lauren Riker, reporting

6. ROUTINESC14D9CPacira BioSciences, Inc.PCRXOct 8

   Pacira BioSciences to be acquired by Viatris

   • Viatris to acquire Pacira for $36.50 per share in cash
   • Transaction expected to close by end of 2026
   • Pacira's portfolio and pipeline to become part of Viatris's innovative medicines
7. ROUTINESC TO-CPacira BioSciences, Inc.PCRXOct 8

   Pacira BioSciences, Inc. (PCRX) announces acquisition by Viatris Inc.

   • Viatris Inc. plans to acquire Pacira BioSciences, Inc.
   • The acquisition includes all outstanding shares of Pacira's common stock.
   • The tender offer is expected to be accretive to Viatris's portfolio.

   Viatris Inc, filed by

8. ROUTINE4Pacira BioSciences, Inc.PCRXAug 18

   Jonathan Slonin, insider filing for PCRX

   Jonathan Slonin, reporting

9. ROUTINE144Pacira BioSciences, Inc.PCRXAug 17

   Jonathan Slonin, planned sale of PCRX shares

   Jonathan Slonin, reporting

10. ROUTINESCHEDULE 13GPacira BioSciences, Inc.PCRXAug 7

    Ownership stake disclosure by STATE STREET CORP

    STATE STREET CORP, filed by

11. ROUTINES-8Pacira BioSciences, Inc.PCRXAug 4

    Employee stock plan registration

12. NOTABLE10-QPacira BioSciences, Inc.PCRXAug 4

    Quarterly report

13. ROUTINE8-KPacira BioSciences, Inc.PCRXAug 4

    Current report

14. ROUTINE8-KPacira BioSciences, Inc.PCRXJun 30

    Current report

15. ROUTINE4Pacira BioSciences, Inc.PCRXJun 12

    10 insider filings

    Lauren Riker, insider filing for PCRX

    Show all 10

    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 4Insider filing for PCRXJun 12
    • 3New insider at PCRXJun 12

    Lauren Riker, reporting

16. ROUTINE144Pacira BioSciences, Inc.PCRXJun 12

    Abraham Ceesay, planned sale of PCRX shares

    Abraham Ceesay, reporting

17. ROUTINE8-KPacira BioSciences, Inc.PCRXJun 11

    Current report

18. ROUTINE144Pacira BioSciences, Inc.PCRXJun 11

    Lauren Riker, planned sale of PCRX shares

    Lauren Riker, reporting

19. ROUTINE4Pacira BioSciences, Inc.PCRXJun 5

    3 insider filings

    Lauren Riker, insider filing for PCRX

    Show all 3

    • 4Insider filing for PCRXJun 5
    • 4Insider filing for PCRXJun 5
    • 4Insider filing for PCRXJun 5

    Lauren Riker, reporting

20. ROUTINEDEFA14APacira BioSciences, Inc.PCRXJun 4

    Additional proxy materials

21. ROUTINE144Pacira BioSciences, Inc.PCRXJun 4

    Kristen Williams, planned sale of PCRX shares

    Kristen Williams, reporting

22. ROUTINEDEFA14APacira BioSciences, Inc.PCRXJun 1

    Additional proxy materials

23. ROUTINEDFAN14APacira BioSciences, Inc.PCRXMay 28

    DFAN14A filing

    Doma Perpetual Capital Management LLC, filed by

24. ROUTINEDEFA14APacira BioSciences, Inc.PCRXMay 28

    Additional proxy materials

25. ROUTINEDEFA14APacira BioSciences, Inc.PCRXMay 27

    Additional proxy materials

26. ROUTINEDEFA14APacira BioSciences, Inc.PCRXMay 26

    Additional proxy materials

27. ROUTINEDFAN14APacira BioSciences, Inc.PCRXMay 21

    DFAN14A filing

    Doma Perpetual Capital Management LLC, filed by

28. ROUTINEDEFA14APacira BioSciences, Inc.PCRXMay 20

    Additional proxy materials

29. ROUTINEDFAN14APacira BioSciences, Inc.PCRXMay 20

    DFAN14A filing

    Doma Perpetual Capital Management LLC, filed by

30. ROUTINEDEFA14APacira BioSciences, Inc.PCRXMay 13

    Additional proxy materials

31. ROUTINEDFAN14APacira BioSciences, Inc.PCRXMay 13

    DFAN14A filing

    Doma Perpetual Capital Management LLC, filed by

32. ROUTINEDEFC14APacira BioSciences, Inc.PCRXMay 12

    DEFC14A filing

    Doma Perpetual Capital Management LLC, filed by

33. ROUTINEDFAN14APacira BioSciences, Inc.PCRXMay 12

    DFAN14A filing

    Doma Perpetual Capital Management LLC, filed by

34. ROUTINEDEFA14APacira BioSciences, Inc.PCRXMay 12

    Additional proxy materials

35. ROUTINEPRRN14APacira BioSciences, Inc.PCRXMay 8

    PRRN14A filing

    Doma Perpetual Capital Management LLC, filed by

36. ROUTINEDEFA14APacira BioSciences, Inc.PCRXMay 5

    Additional proxy materials

37. NOTABLE10-QPacira BioSciences, Inc.PCRXApr 30

    Quarterly report

38. ROUTINE8-KPacira BioSciences, Inc.PCRXApr 30

    Current report

39. ROUTINEDEFA14APacira BioSciences, Inc.PCRXApr 28

    Additional proxy materials

Older filings on EDGAR